πŸ‡ΊπŸ‡Έ FDA
Patent

US 8263085

Gammaretrovirus associated with cancer

granted A61KA61K39/00A61P

Quick answer

US patent 8263085 (Gammaretrovirus associated with cancer) held by The Regents of the University of California expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K39/00, A61P, A61P31/12, A61P31/14